Peter Tessier, PhD
Peter Tessier, PhD, is the Albert M. Mattocks Professor of Pharmaceutical Sciences and Chemical Engineering in the Departments of Chemical Engineering and Pharmaceutical Sciences (equal appointments), and a member of the Biointerfaces Institute, at the University of Michigan in Ann Arbor, MI. He received his B.S. degree in chemical engineering from the University of Maine (1998, co-valedictorian), and his PhD in chemical engineering from the University of Delaware (2003, NASA Graduate Fellow). Tessier performed his postdoctoral studies at the Whitehead Institute for Biomedical Research at MIT (2003-2007, American Cancer Society Fellow). Tessier started his independent career as an assistant professor in the Department of Chemical & Biological Engineering at Rensselaer Polytechnic Institute in 2007, and he was an endowed full professor (Richard Baruch, MD, Career Development Professor of Chemical & Biological Engineering) prior to his move to the University of Michigan in 2017. Tessier’s research focuses on designing, optimizing, characterizing and formulating a class of large therapeutic proteins (antibodies) that hold great potential for detecting and treating human disorders ranging from cancer to Alzheimer’s disease. He has received a number of awards in recognition of his pioneering work, including a Humboldt Fellowship for Experienced Researchers (2014-15), a Young Scientist Award from the World Economic Forum (2014), a Biochemical Engineering Journal Young Investigator Award (2016), a Young Investigator Award from the Biochemical Technology division of the American Chemical Society (2015), a Pew Scholar Award in Biomedical Sciences (2010-14), a National Science Foundation CAREER Award (2010-15), a Rensselaer Early Career Award (2012), and Rensselaer School of Engineering Research (2012) and Teaching (2013) Awards.